← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Net income increased 14.2% to ($19.4M), while Operating cash flow decreased 22.0% to ($15.2M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue N/AWatch
- Profitability — Net income ($19.4M)Watch
- Cash generation — Free cash flow ($15.3M)Note
- Accounting — Formula distress score · manipulation and earnings-quality screens not computedWatch
- Insiders — 0 buys; 0 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Business
Glucotrack, Inc.: The Company was founded with a mission to develop Glucotrack®, a non-invasive glucose monitoring device designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices.
Leadership changes
From Glucotrack, Inc.'s own filings, the day they're filed.
- Peter Wulff · Chief Financial Officer · departureeff. 2025-01-28
- Peter C. Wulff · Chief Financial Officer · departureeff. 2025-01-28
- James Cardwell · Chief Financial Officer · departureeff. 2025-01-27
Latest filings
- 8-K · Company announcement2026-08-28
- 8-K · Company announcement2026-08-27
- 8-K · Company announcement2026-08-19
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-08-10
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Glucotrack, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.